// App-Quantinova.ai

581 : Thrombosis, Bleeding, and the Effect of Anticoagulation on Survival in Critically Ill Patients with COVID-19 in the United States

Researchers

Presenter

  • Hanny Al-Samkari

Principal Investigators

  • Shruti Gupta

  • Rebecca Karp Leaf

  • Wei Wang

  • Rachel P. Rosovsky

  • Kenneth A. Bauer

  • David E. Leaf

Medical Centers

  • Harvard Medical School, Boston, MA

  • Division of Rheumatology, Massachusetts General Hopsital, Boston, MA,

  • Division of Sleep and Circadian Disorders, Brigham and Womens Hospital, Boston, MA

  • Brigham and Women's Hospital, Brookline, MA

  • Medicine - Hematology/Oncology, Beth Israel Deaconess Medical Center, Boston, MA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Infectious Diseases (ID)

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

Disease

  • Venous thrombosis

  • Coronavirus disease

Biomarkers

  • D-dimer

Drug/Treatment

  • Heparin

Outcome

  • N/A


Study Design

  • Multicenteric

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A